Renu Bhargavi Boyapati

IM PGY 2 BRG || Research Collaborator @Mayo Clinic || HEME-ONC || Dancer

[Bloodman @Bloodman]

Big news - Jehovah’s Witnesses can receive PRBC, platelets FFP etc if they want https://t.co/rHpn3kYI8n

[Ariela Marshall MD @AMarshallMD]

Thrilled to join the ROON team in its mission to help physicians connect and share knowledge and so excited to help launch the #Hematology community!
@ASH_hematology @ASCO
#MedEd #Healthcare #Medicine

[Rami Manochakian MD, FASCO @RManochakian]

🚨Dear friends & colleagues

Dr. @rachnatshroff, a great leader in the #Oncology field, and a wonderful #clinician, #researcher, #educator and #mentor who dedicated her career to help patients fight #Cancer, is now fighting her own cancer, and has taken on the noble mission to establish an:

⭐️#Endowed #ConquerCancer – Rachna Shroff, MD, MS, FASCO Young Investigator Award (#YIA) in #BiliaryCancer.

🙏Let’s please help her reach the goal & fund, that will empower the next generations of #scientists to keep conquering cancer.

👇🏻
https://t.co/nTITHSQluB

[Ariela Marshall MD @AMarshallMD]

Gloria Steinem was a fierce advocate for #womensrights, an entrepreneur, an author, and a leading pillar of feminism. Her death will be felt deeply by those of us continuing the work for #genderequity
https://t.co/tfrV6BhvPX

[Renu Bhargavi Boyapati @RenuB369]

@HemOncFellows @sawyer_bawek @DrSAHaddad @KalantriShreyas @Charbel_matar1 @msalmanfaisal @Noha_Soror @Mahaematology @AndreaAnampaG Preparation tips to answer your research questions well
Do Not’s in answering

[Renu Bhargavi Boyapati @RenuB369]

@AMarshallMD @ASCO @ASH_hematology @rmistry91 Congratulations Dr. Marshall

[ASH @ASH_hematology]

A new study of the bispecific antibody (BsAb) epcoritamab for the treatment of Richter transformation highlights the difficulty of managing patients with this disease, as well as the potential impacts of prior therapy on long-term outcomes. Read more: https://t.co/m6FCIGkc6u

[Renu Bhargavi Boyapati @RenuB369]

@AMarshallMD @UMNews Congratulations Dr. Marshall

[Ariela Marshall MD @AMarshallMD]

#WomensHealth intersects with #Hematology in many ways - early #Education is so important to raise awareness! Thank you @ASH_hematology Clinical News for the opportunity to contribute to this article!

https://t.co/qAJddCRMur

#GenderEquity #MedEd

[Jame Abraham, MD, FACP @jamecancerdoc]

This is probably the most promising data coming out of @ASCO #ASCO26 - finally our patients with pancreatic cancer has a better option than chemo - ! @OncoAlert

[Agrima Mian @AgrimaMianMD]

Late breaking from #ASCO26 Day 2 for Lymphoma- FrontMIND trial

👉 Tafa+ Len + RCHOP vs RCHOP in 1L DLBCL IPI 3-5
👉 HR for PFS 0.75
👉 2 yr median PFS 72% vs 65%
👉 overall rate G3/4 TEAEs comparable, but increased cytopenias; febrile neutropenia in Tafa/Len/RCHOP
⭐️Potential new SOC option for 1L DLBCL in high risk pts, regardless of COO.
My concerns : Difficult regimen with weekly Tafa and 10 days of Len; higher myelosuppression/VTE risk with Len; plus concern of CD19 loss and efficacy of 2L CAR 🚗

[Renu Bhargavi Boyapati @RenuB369]

@Sai_Wannaphut @binaytara @oncodaily @IMG_Oncologists @HemOncFellows @MedicalwatchHQ @T4Cancer @AmericanCancer @hemeoncfellow @WHO @NIH Congratulations Sai

[ASH @ASH_hematology]

Too many people with sickle cell disease face fragmented care. Congress can fix this. Urge your Senators and Representatives to cosponsor the Sickle Cell Disease Comprehensive Care Act (S.721/H.R.5178) today!

Act now: https://t.co/z3X65Ic9my

#SCD #SCDCCA

[Oncology Brothers @OncBrothers]

Highlights from #ASH25 #CommunityOnc:

#Lymphoma
1. #EPCOREFL1 FL
2. #CLL17 CLL
3. #BRUIN313/314 CLL
4. #S1826 HL

#Myeloma
5. #COBRA
6. #MajesTEC3
7. #AQUILA
8. #RedirecTT1

#Leukemia
9. #PARADIGM

@ASH_hematology #lymsm #mmsm #HemeTwitter 1/10

[Renu Bhargavi Boyapati @RenuB369]

#ASH2025 has been a truly wonderful experience, learnt advancements in hematology, along with opportunity to meet renowned Hematologists and Colleagues, oral and poster presentation.
#ASH2025 #ASHtrainees

[Vincent Rajkumar @VincentRK]

OK here it is. Finally.
My #ASH25 algorithm for Relapsed Myeloma: First Relapse. Discussed with @YiLinMDPhD @myelomaMD

Give comments. I’m willing to adjust it based on your insights.

[Renu Bhargavi Boyapati @RenuB369]

@AgrimaMianMD @ASH_hematology @ClevelandClinic Congratulations, this is outstanding.

[Agrima Mian @AgrimaMianMD]

Day -1 to the best and biggest trainee event @ASH_hematology!

Trainees attending #ASH25- come join us tomorrow at @SeaWorld for an exciting day of learning, networking and celebrating together!

We can’t wait to see you at #ASHaPalooza!
#ASHTrainee #ASHScavengerHunt

[Renu Bhargavi Boyapati @RenuB369]

Wonderful time spent at SOHO 2025.
Happy to have taken part in R/R CLL initiative, had an opportunity to interact with the experts from the field Dr. Meghan Thompson and Dr. Catherine Coombs.
#soho2025 #MSKCancerCenter #UCIrvineHealth #CLL

[Vincent Rajkumar @VincentRK]

I’ve said it before. I’ll say it again.

Healthcare is extraordinarily expensive. The public gets health insurance, and pays premiums faithfully believing that when illness strikes, insurance will cover what their doctor prescribes.

Insurance denials and prior auth should not be used to delay, modify, or prevent legitimate care. That removes the vital safety net. Patients are already suffering and vulnerable from their serious illness. They don’t need the added anguish of whether they will go bankrupt due to medical bills.